Glucolipotoxicity: Fuel Excess and β-Cell Dysfunction
Open accessThe DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Abstract
Glucotoxicity, lipotoxicity, and glucolipotoxicity are secondary phenomena that are proposed to play a role in all forms of type 2 diabetes. The underlying concept is that once the primary pathogenesis of diabetes is established, probably involving both genetic and environmental forces, hyperglycemia and very commonly hyperlipidemia ensue and thereafter exert additional damaging or toxic effects on the beta-cell. In addition to their contribution to the deterioration of beta-cell function after the onset of the disease, elevations of plasma fatty acid levels that often accompany insulin resistance may, as glucose levels begin to rise outside of the normal range, also play a pathogenic role in the early stages of the disease. Because hyperglycemia is a prerequisite for lipotoxicity to occur, the term glucolipotoxicity, rather than lipotoxicity, is more appropriate to describe deleterious effects of lipids on beta-cell function. In vitro and in vivo evidence supporting the concept of glucotoxicity is presented first, as well as a description of the underlying mechanisms with an emphasis on the role of oxidative stress. Second, we discuss the functional manifestations of glucolipotoxicity on insulin secretion, insulin gene expression, and beta-cell death, and the role of glucose in the mechanisms of glucolipotoxicity. Finally, we attempt to define the role of these phenomena in the natural history of beta-cell compensation, decompensation, and failure during the course of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The basis for this loss is multifactorial, and includes glucolipotoxicity32 and amyloid deposition that result in β-cell apoptosis through oxidative as well as endoplasmic reticulum stress31.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
Research works printed but not linked: 1
- Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, Unger RH 1998 Lipoapoptosis in β-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 273:32487–32490 [DOI] [PubMed] [Google Scholar]
Cited by
Items 601–700 of 999
Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Pancreatic β-Cell Mass and Function
Nakamura, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095104 · Cited by 20
Tracers and Imaging of Fatty Acid and Energy Metabolism of Human Adipose Tissues
Carpentier, A. C. (2023) · Physiology · doi:10.1152/physiol.00012.2023 · Cited by 27
Astiarraga, B., Chueire, V. B., de Souza, A. L., Moreira, R. P., Alegre, S. M., Natali, A., Tura, A., Mari, A., Ferrannini, E., & Muscelli, E. (2018) · Diabetologia · doi:10.1007/s00125-018-4633-z · Cited by 21
Mullooly, N., Vernon, W., Smith, D. M., & Newsholme, P. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2013.077495 · Cited by 20
Veluthakal, R., Suresh, M. V., & Kowluru, A. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0113-6 · Cited by 18
“In a recent review, Poitout and Robertson discussed potential functional consequences of glucolipotoxicity on islet b-cells function, including suppression of insulin gene expression, insulin secretion and cell death [35].”
BackgroundPotential role of Hsp90 in rat islet function under the condition of high glucose
Yang, X. F., Zhang, Y., Wan, X., Deng, R., Liu, Y., Li, F., Wang, Y., Ji, X., Bai, M., Zhou, F., et al. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0852-2 · Cited by 19
Oguri, M., Fujimaki, T., Horibe, H., Kato, K., Matsui, K., Takeuchi, I., & Yamada, Y. (2016) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2016.08.008 · Cited by 20
Coffee, type 2 diabetes and pancreatic islet function – A mini-review
Costabile, A., Sarnsamak, K., & Hauge-Evans, A. C. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.04.011 · Cited by 21
Temporal Proteomic Analysis of Pancreatic β-Cells in Response to Lipotoxicity and Glucolipotoxicity
Li, Z., Liu, H., Niu, Z., Zhong, W., Xue, M., Wang, J., Yang, F., Zhou, Y., Zhou, Y., Xu, T., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.000698 · Cited by 22
The Phosphatase PHLPP2 Plays a Key Role in the Regulation of Pancreatic Beta-Cell Survival
Hribal, M. L., Mancuso, E., Arcidiacono, G. P., Greco, A., Musca, D., Procopio, T., Ruffo, M., & Sesti, G. (2020) · International Journal of Endocrinology · doi:10.1155/2020/1027386 · Cited by 18
Zhang, Q., Wu, S., Sun, G., Zhang, R., Li, X., Zhang, Y., Huang, F., & Yuan, D. (2021) · Annals of Translational Medicine · doi:10.21037/atm-19-4738 · Cited by 17
“Previous studies have confirmed that long-term hyperglycemia not only leads to the overexpression of reactive oxygen species (ROS) and inhibition of nitric oxide (NO) activity, but also to the activation of signaling pathways including the protein kinase C (PKC) and nuclear factor-kappa B (NF-κB) pathways, which can r…”
BackgroundGlucagon: The renewal of an old hormone in the pathophysiology of diabetes (胰升糖素:一种老激素在糖尿病病理生理中的新作用)
Gosmain, Y., Masson, M. H., & Philippé, J. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12022 · Cited by 19
“Glucotoxicity, lipotoxicity, and glucolipotoxicity are secondary phenomena that have been shown to considerably affect b-cell function and particularly insulin biosynthesis and secretion.(14) These deleterious effects are beyond the primary pathogenesis of diabetes involving both genetic and environmental components.”
InfluentialXiao, C., Giacca, A., & Lewis, G. F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00183.2011 · Cited by 19
Walters, S. N., Luzuriaga, J., Chan, J. Y., Grey, S. T., & Laybutt, D. R. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0016 · Cited by 19
Protection of Human Pancreatic Islets from Lipotoxicity by Modulation of the Translocon
Cassel, R., Ducreux, S., Alam, M. R., Dingreville, F., Berlé, C., Burda-Jacob, K., Chauvin, M., Chikh, K., Païta, L., Al-Mawla, R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148686 · Cited by 24
“Therefore, we guess, in accordance with the literature, that restorations of ER calcium homeostasis should allow suitable insulin secretion in response to glucose and ER calcium liberation [43,53].”
BackgroundResultShehata, M. M., Kamal, M. M., El-Hefnawy, M. H., & EL-Mesallamy, H. O. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.001 · Cited by 17
DNAJB3 attenuates metabolic stress and promotes glucose uptake by eliciting Glut4 translocation
Arredouani, A., Diané, A., Khattab, N., Bensmail, I., Aoudé, I., Chikri, M., Mohammad, R. M., Abou‐Samra, A., & Dehbi, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-41244-8 · Cited by 18
Glucolipotoxicity and GLP-1 secretion
Hong, J.-H., Kim, D., & Lee, M. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001905 · Cited by 17
Characteristics associated with early- vs. later-onset adult diabetes: The CARDIA study
Cha, E., Pasquel, F. J., Yan, F., Jacobs, D. R., Dunbar, S. B., Umpierrez, G. E., Choi, Y., Shikany, J. M., Bancks, M. P., Reis, J. P., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109144 · Cited by 21
Syed, I., Szulc, Z. M., Öğretmen, B., & Kowluru, A. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000341481 · Cited by 17
Ngo, A. T., Sutherland, D. E. R., Beilman, G. J., & Bellin, M. D. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0315-8 · Cited by 18
“Elevations in circulating fatty acids induced by corticosteroids may cause further damage to the beta cells in the face of high glucose, a concept known as glucolipotoxicty [11].”
Small‐molecule inhibition of inflammatory β ‐cell death
Lundh, M., Scully, S. S., Mandrup-Poulsen, T. R., & Wagner, B. K. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12158 · Cited by 17
“The mechanism of action is not completely understood, but substantial evidence suggests several contributors to apoptosis, such as ROS formation, oxidative stress and induction of ER stress (reviewed in [70,71]).”
BackgroundTranscription factor 7-like 2 gene links increased in vivo insulin synthesis to type 2 diabetes
Jainandunsing, S., Koole, H. R., van Miert, J. N. I., Rietveld, T., Wattimena, J. L. D., Sijbrands, E. J. G., & de Rooij, F. W. M. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.03.026 · Cited by 19
“Although other factors like glucotoxicitymight lead toβ cell dysfunction in type 2 diabetes through reduced insulin gene expression (Poitout and Robertson, 2008, Ottosson-Laakso et al., 2017), our data demonstrate that among our individuals with type 2 diabetes there is actually a shift from…”
BackgroundYakhchalian, N., mohammadian, N., Hatami, K., Nosrati, H., & Yousofvand, N. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/359844 · Cited by 23
Yildirim, V., Sheraton, V. M., Brands, R., Crielaard, L., Quax, R., van Riel, N. A. W., Stronks, K., Nicolaou, M., & Sloot, P. M. A. (2023) · iScience · doi:10.1016/j.isci.2023.108324 · Cited by 19
Lipotoxicity: The missing link between diabetes and periodontitis?
Sun, Y. L., Yin, Y., Yang, S., Ai, D., Qin, H., Xia, X., Xu, X., & Song, J. (2024) · Journal of Periodontal Research · doi:10.1111/jre.13242 · Cited by 18
Saha, T., Mehrotra, S., Gupta, P., & Kumar, A. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123140 · Cited by 17
González-Pertusa, J. A., Dubé, J. J., Valle, S. R., Rosa, T. C., Takane, K. K., Mellado‐Gil, J. M., Perdomo, G., Vasavada, R. C., & García-Ocaña, A. (2010) · Endocrinology · doi:10.1210/en.2009-0975 · Cited by 16
Oxidative and energetic stresses mediate beta-cell dysfunction induced by PGC-1α
Besseiche, A., Riveline, J., Delavallée, L., Foufelle, F., Gautier, J. F., & Blondeau, B. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.01.007 · Cited by 18
“antioxidant enzymes preserved insulin promoter activity, Pdx1-binding and levels of insulin mRNA despite high glucose concentrations in studies in vitro [21] while, in animal studies,”
BackgroundAdmin, A., Li, R., Kondegowda, N. G., Filipowska, J., Hampton, R. F., Leblanc, S., García-Ocaña, A., & Vasavada, R. C. (2020) · Diabetes · doi:10.2337/db19-0909 · Cited by 17
Storz, M. A. (2020) · PubMed · doi:10.15586/jptcp.v27sp2.744 · Cited by 16
PrayGod, G., Filteau, S., Range, N. S., Ramaiya, K. L., Jeremiah, K., Rehman, A. M., Krogh‐Madsen, R., Friis, H., & Faurholt‐Jepsen, D. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262860 · Cited by 16
Diabetes duration and types of diabetes treatment in data-driven clusters of patients with diabetes
Zhang, J., Deng, Y., Wan, Y., Wang, J., & Xu, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.994836 · Cited by 20
Fat feeding potentiates the diabetogenic effect of dexamethasone in Wistar rats
Sivabalan, S., Renuka, S., & Menon, V. P. (2008) · International Archives of Medicine · doi:10.1186/1755-7682-1-7 · Cited by 17
“It have also been reported that the role of free fatty acid in the development of diabetes is a secondary phenomenon [20].”
InfluentialGosmanov, A. R. (2016) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2016.05.002 · Cited by 19
Diabetes mellitus: The pathophysiology as a canvas for management elucidation and strategies
Iheagwam, F. N., & Iheagwam, O. T. (2025) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2025.100351 · Cited by 32
Biogenesis of the Insulin Secretory Granule in Health and Disease
Guest, P. C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12668-1_2 · Cited by 18
Chan, P., Liao, M.-T., Lu, C., Tian, Y., & Hsieh, P. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173703 · Cited by 15
Ramos, J. S., Dalleck, L. C., Borrani, F., Fassett, R. G., & Coombes, J. S. (2016) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2016.04.007 · Cited by 17
MicroRNAs in islet immunobiology and transplantation
Pileggi, A., Klein, D., Fotino, C., Bravo-Egaña, V., Rosero, S., Doni, M., Podetta, M., Ricordi, C., Molano, R. D., & Pastori, R. L. (2013) · Immunologic Research · doi:10.1007/s12026-013-8436-5 · Cited by 17
Himabindu, B., Madhu, P., & Reddy, P. S. (2014) · Reproductive Toxicology · doi:10.1016/j.reprotox.2014.12.010 · Cited by 17
Liu, L., Chowdhury, S., Fang, X., Liu, J., & Srikant, C. B. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.030 · Cited by 14
Systematic investigation into the role of intermittent high glucose in pancreatic beta-cells.
Shao, C., Gu, J., Meng, X., Zheng, H., & Wang, D. (2015) · PubMed Central · Cited by 19
RNA-seq-based identification of Star upregulation by islet amyloid formation
Hogan, M. F., Ziemann, M., Kaipananickal, H., Rodriguez, H., Kaspi, A., Esser, N., Templin, A. T., El‐Osta, A., & Kahn, S. E. (2019) · Protein Engineering Design and Selection · doi:10.1093/protein/gzz022 · Cited by 15
Wang, L., Duan, J., Jia, N., Liu, M., Cao, S., Weng, Y., Zhang, W., Cao, J., Li, R., Cui, J., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8832318 · Cited by 18
Insulin resistance in diabetes: The promise of using induced pluripotent stem cell technology
Elsayed, A. K., Vimalraj, S., Nandakumar, M., & Abdelalim, E. M. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i3.221 · Cited by 16
Revisiting Regulators of Human β-cell Mass to Achieve β-cell–centric Approach Toward Type 2 Diabetes
Sasaki, H., Saisho, Y., Inaishi, J., & Itoh, H. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab128 · Cited by 18
JunD Regulates Pancreatic β-Cells Function by Altering Lipid Accumulation
Wang, K., Cui, Y., Lin, P., Yao, Z., & Sun, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.689845 · Cited by 21
Hasan, S., Soltman, S., Wood, C. L., & Blackman, S. M. (2021) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2021.100287 · Cited by 19
Mohammad, T., de Souza, A. H., Bensellam, M., Chae, H., Jaffredo, M., Close, A.-F., Deglasse, J.-P., Santos, L. R. B., Buémi, A., Mourad, N. I., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05842-y · Cited by 16
Protective effects of arachidonic acid against palmitic acid-mediated lipotoxicity in HIT-T15 cells
Cho, Y. S., Kim, C. H., Kim, K. Y., & Cheon, H. G. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-1200-z · Cited by 15
Heterogeneidade do diabetes melito tipo 1
Dib, S. A. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000200008 · Cited by 20
Obesity, Type 2 Diabetes and Beta Cell Failure: An Asian Perspective
Saisho, Y. (2014) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.s1-008 · Cited by 18
Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice
Liu, Y., Cheng, X., Zhang, T., Lee, S., Yamauchi, J., Xiao, X., Gittes, G. K., Qu, S., Jiang, C., & Dong, H. H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.707885 · Cited by 16
Meng, X., Zhu, B., Liu, Y., Fang, L., Yin, B., Sun, Y., Ma, M., Huang, Y., Zhu, Y., & Zhang, Y. (2021) · Journal of Diabetes Research · doi:10.1155/2021/6689414 · Cited by 19
“Many studies have associated glucolipotoxicity with β cell dysfunction in type 2 diabetes, suggesting that metabolites are likely causally related to diabetes development [52].”
BackgroundLiu, J., Liu, D., Wang, N., Lin, H.-L., & Mei, X. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05545.x · Cited by 14
“Chronic hyperglycaemia has been suggested to affect multiple biochemical pathways and mechanisms to cause chronic oxidative stress.(1,2) Chronic oxidative stress could have adverse effects on the islets, which is one of the tissues with the lowest levels of intrinsic anti-oxidant defences.”
BackgroundSweet and Sour β-Cells: ROS and Hif1α Induce Warburg-Like Lactate Production During Type 2 Diabetes
Cantley, J., & Biden, T. J. (2013) · Diabetes · doi:10.2337/db13-0272 · Cited by 17
HIF-2α Preserves Mitochondrial Activity and Glucose Sensing in Compensating β-Cells in Obesity
Moon, J.-S., Riopel, M., Seo, J. B., Herrero-Aguayo, V., Isaac, R., & Lee, Y. S. (2022) · Diabetes · doi:10.2337/db21-0736 · Cited by 13
Fuentes-Barría, H., Aguilera-Eguía, R. A., Flores-Fernández, C., Angarita, L., & Alarcón-Rivera, M. (2026) · Biomedicines · doi:10.3390/biomedicines14040752 · Cited by 22
Interplay of fatty acids, insulin and exercise in vascular health
Anderson, K. C., Liu, J., & Liu, Z. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-024-02421-5 · Cited by 20
Couté, Y., Brunner, Y., Schvartz, D., Hernandez, C., Masselot, A., Lisacek, F., Wollheim, C. B., & Sanchez, J. (2009) · PROTEOMICS · doi:10.1002/pmic.200900080 · Cited by 14
“Therefore, the term lipotoxicity was recently replaced by glucolipotoxicity [7].”
BackgroundHyperoxia reverses glucotoxicity-induced inhibition of insulin secretion in rat INS-1 β cells
Matsunaga, T., Li, S., Adachi, T., Joo, E., Gu, N., Yamazaki, H., Yasuda, K., Kondoh, T., & Tsuda, K. (2014) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2014.905175 · Cited by 13
Russo, G. T., Giorda, C. B., Cercone, S., Cosmo, S. D., Nicolucci, A., Cucinotta, D., & the BetaDecline Study Group (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3016 · Cited by 13
Cheng, X., Huang, Y., Yang, P., & Bu, L. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118571 · Cited by 14
Ni, Q., Song, J., Wang, Y., Sun, J., Xie, J., Zhang, J., Ning, G., Wang, W., & Wang, Q. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa786 · Cited by 15
von Hanstein, A., Tsikas, D., Lenzen, S., Jörns, A., & Plötz, T. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200582 · Cited by 13
Lapuerta, P., Rosenstock, J., Zambrowicz, B., Powell, D. R., Ogbaa, I., Freiman, J. P., Cefalu, W. T., Banks, P. L., Frazier, K., Kelly, M., et al. (2013) · Clinical Cardiology · doi:10.1002/clc.22125 · Cited by 13
Doliba, N. M., Liu, Q., Li, C., Chen, J., Chen, P., Liu, C., Frederick, D. W., Baur, J. A., Bennett, M. J., Naji, A., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.09.010 · Cited by 14
Venkatesan, T., Vijayaraghavan, K., & Subramanian, S. P. (2012) · Biomedicine & Preventive Nutrition · doi:10.1016/j.bionut.2012.07.002 · Cited by 14
Novel Strategies for Inducing Glycemic Remission during the Honeymoon Phase of Type 2 Diabetes
Retnakaran, R. R. (2015) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2015.08.007 · Cited by 16
A 3-year follow-up study of β-cell function in patients with early-onset type 2 diabetes
Zhou, S., Meng, X., Wang, S., Ren, R., Hou, W., Huang, K., & Shi, H. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3394 · Cited by 13
¿Cuándo empieza la diabetes? Detección e intervención tempranas en diabetes mellitus tipo 2
Peralta, F. G., Abreu, C., Cos, X., & Gómez‐Huelgas, R. (2020) · Revista Clínica Española · doi:10.1016/j.rce.2019.12.003 · Cited by 29
Mirhashemi, F., Kluth, O., Scherneck, S., Vogel, H., Kluge, R., Schürmann, A., Joost, H., & Neschen, S. (2008) · Obesity Facts · doi:10.1159/000176064 · Cited by 16
Morse, D. R., Cohen, L., Furst, M. L., & Martin, J. S. (1984) · PubMed · Cited by 14
Vangoitsenhoven, R., van der Ende, M., Corbeels, K., da Cunha, J. P. M. C. M., Lannoo, M., Bédossa, P., der Merwe, V., Mertens, A. C., Gesquiere, I., Meulemans, A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200779 · Cited by 13
Insulin gene expression and biosynthesis
Poitout, V., Stein, R. W., & Rhodes, C. J. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch6 · Cited by 13
Self-citationLallement, J., Raho, I., Merlen, G., Rainteau, D. P., Croyal, M., Schiffano, M., Kassis, N., Doignon, I., Soty, M., Lachkar, F., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159333 · Cited by 19
“Thus, this specific class of lipids, which belongs to sphingolipids (SL) family, are proposed to be important mediators of free-fatty acid (FFA)-induced β cell dysfunction and apoptosis, and FFA-induced insulin resistance in insulin target tissue [2].”
BackgroundYang, Y., Wang, B., Dong, H., Lin, H., Ho, M. Y.-M., Hu, K., Zhang, N., Ma, J., Xie, R., Cheng, K. K. Y., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2401218121 · Cited by 16
Schmitt, H., Lenzen, S., & Baltrusch, S. (2011) · Diabetologia · doi:10.1007/s00125-011-2133-5 · Cited by 13
“Chronically high concentrations of glucose and NEFA have been proposed to contribute to beta cell dysfunction and death [22].”
BackgroundYamauchi, Y., Nakamura, A., Yokota, T., Takahashi, K., Kawata, S., Tsuchida, K., Omori, K., Nomoto, H., Kameda, H., Cho, K. Y., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-13888-6 · Cited by 14
Thomsen, M. N., Skytte, M. J., Samkani, A., Astrup, A. V., Fenger, M., Frystyk, J., Hartmann, B., Holst, J. J., Larsen, T. M., Madsbad, S., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.933118 · Cited by 12
Balancing needs and means: the dilemma of the β‐cell in the modern world
Leibowitz, G., Kaiser, Ν., & Cerasi, E. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01101.x · Cited by 12
Incretin-based therapy and pancreatic beta cells
Chon, S., Riveline, J., Blondeau, B., & Gautier, J. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.05.003 · Cited by 13
Lee, H.-J., Choi, Y., Park, S., Kim, J., Won, K. C., Son, J., & Kim, Y. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.1.51 · Cited by 20
“This condition is known as “glucotoxicity” [1-4].”
BackgroundOxidative stress: link between hypertension and diabetes
Moon, J. S., & Won, K. C. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2017.153 · Cited by 12
Jiang, Y., Jiang, F., Li, M., Wu, Q., Xu, C., Zhang, R., Song, M., Wang, Y., Wang, Y., Chen, Y., et al. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04374-8 · Cited by 10
Nagao, Y., Amo-Shiinoki, K., Nakabayashi, H., Hatanaka, M., Kondo, M., Matsunaga, K., Emoto, M., Okuya, S., Tanizawa, Y., & Tanabe, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113586 · Cited by 13
Ahmed, I., Chakraborty, R., Faizy, A. F., & Moin, S. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01496-2 · Cited by 14
Free Fatty Acid Receptor 1: A New Drug Target for Type 2 Diabetes?
Ferdaoussi, M., Bergeron, V., Kebede, M. A., Mancini, A. D., Alquier, T., & Poitout, V. (2012) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2012.08.002 · Cited by 12
Self-citationEffect of 2-hydroxychalcone on adiponectin level in type 2 diabetes induced experimentally in rats
Eissa, L. A., Elsherbiny, N. M., & Maghmomeh, A. O. (2017) · Egyptian Journal of Basic and Applied Sciences · doi:10.1016/j.ejbas.2016.12.002 · Cited by 11
Increased pancreatic-derived factor (PANDER) levels in gestational diabetes mellitus
Köroğlu, N., Yüksel, İ. T., Çetin, B. A., Tola, E. N., Selçuki, N. F. T., Turhan, U., & Yıldırım, G. Y. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1599856 · Cited by 11
Liu, J.-J., Gurung, R. L., Liu, S., Yiamunaa, M., Lee, J., Ang, K., Tavintharan, S., Tang, W. E., Sum, C. F., & Lim, S. C. (2021) · Diabetes & Metabolism · doi:10.1016/j.diabet.2021.101238 · Cited by 12
Lin28a ameliorates glucotoxicity-induced β-cell dysfunction and apoptosis
Hwang, Y. J., Jung, G., Jeon, W., & Lee, K. (2021) · BMB Reports · doi:10.5483/bmbrep.2021.54.4.255 · Cited by 11
Натрус, Л. В., Osadchuk, Y., Lisakovska, O., Roch, T., Babel, N., Klys, Y., Labudzynskyi, D. О., & Chaikovsky, Y. B. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11529 · Cited by 12
Jayaram, B., Syed, I., Singh, A., Subasinghe, W., Kyathanahalli, C., & Kowluru, A. (2011) · Islets · doi:10.4161/isl.3.2.15016 · Cited by 11
Amyot, J., Benterki, I., Fontès, G., Hagman, D. K., Ferdaoussi, M., Teodoro, T., Volchuk, A., Joly, E. C., & Poitout, V. (2011) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0016 · Cited by 11
Self-citationThe Glucotoxicity Protecting Effect of Ezetimibe in Pancreatic Beta Cells via Inhibition of CD36
Yoon, J. S., Moon, J. S., Kim, Y.-W., Won, K. C., & Lee, H. W. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2016.31.4.547 · Cited by 11
“However, it is widely accepted that prolonged exposure to elevated FAs along with high glucose causes pancreatic β-cell dysfunction and apoptosis, resulting in glucolipotoxicity (1).”
BackgroundInfluentialThe mitochondrial phospholipid cardiolipin is involved in the regulation of T-cell proliferation
Mürke, E., Stoll, S., Lendeckel, U., Reinhold, D., & Schild, L. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.05.001 · Cited by 15
Gezginci-Oktayoğlu, S., Uçar, E. Ö., Sancar‐Baş, S., Kaçar, A. K., Arda, E. S. N., & Bolkent, Ş. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26242 · Cited by 12
“Glucolipotoxicity could have an important role in decompensation phase which occurs during development of type 2 diabetes (Poitout & Robertson, 2008).”
BackgroundCan We RISE to the Challenge of Youth-Onset Type 2 Diabetes?
Buse, J. B., D’Alessio, D. A., & Riddle, M. C. (2018) · Diabetes Care · doi:10.2337/dci18-0025 · Cited by 11
Metadata
- Authors
- Poitout, V., & Robertson, R. P.
- Affiliations
- Pacific Northwest Research Institute (US)
- University of Washington (US)
- Corresponding author
- Poitout, Vincent
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2008-05
- Volume
- 29
- Issue
- 3
- Pages
- 351-366
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC2528858
- OpenAlex
- W2082515526
- Cited by
- 1,092
- References
- 198
- Citations by year
- 2026: 47 · 2025: 55 · 2024: 37 · 2023: 42 · 2022: 38 · 2021: 57 · 2020: 61 · 2019: 50 · 2018: 44 · 2017: 61 · 2016: 79 · 2015: 64 · 2014: 59 · 2013: 81 · 2012: 84
- FWCI
- 81.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (77686)
- National Institute of Diabetes and Digestive and Kidney Diseases (R-01-DK-38325, R01 DK 58096, R01DK038325, R01DK058096)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- glucolipotoxicity, glucotoxicity, lipotoxicity, type 2 diabetes, beta-cell dysfunction, hyperglycemia, hyperlipidemia, oxidative stress, insulin secretion, insulin gene expression, beta-cell death, insulin resistance, beta-cell compensation, beta-cell failure
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Energy Metabolism, Glucose, Humans, Lipid Metabolism, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.